Dermata Therapeutics (DRMA) Q4 2023 Earnings

21MarConfirmed
Q4 2022
Q1 2023
Q3 2023
Q4 2023
-0.63
-0.42
-0.21
0

Details

Expected EPS
N/A
Actual EPS
-0.21
Surprise EPS
-0.21
Surprise Percent
+∞%

Description

Dermata Therapeutics (DRMA) has reported earnings of -0.21 per share for Q4 2023.

0 Comments

Share your thoughts